Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition

Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition

Posted by Corey Marcath on

tPA from Innovative Research was used in the following study:

 

Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition

James R. Partridge, Rebea M. Choy, Abel Silva-Garcia, Chul Yu, Zhe Li, Hing Sham, Brian Metcalf

Journal of Structural Biology
1 March 2019

"...Plasma kallikrein (pKal) is a serine protease responsible for cleaving high molecular-weight kininogen to produce the pro-inflammatory peptide, bradykinin. Unregulated pKal activity can lead to hereditary angioedema (HAE) following excess bradykinin release.tPA from Innovative Research (Novi MI)..."

 

Related products available from Innovative Research also include:

  • Tags: Proteins

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Neutrophil Elastase Contributes to the Early Diabetic Retinopathy
    Mouse Alpha 1 Antitrypsin (A1AT) ELISA Kit from Innovative Research was used in the fol...
    Read the Article
    Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS
    Pooled Human Plasma Apheresis Derived from Innovative Research was used in the followin...
    Read the Article

    ← Older Post Newer Post →